The Board of Directors of Evaxion Biotech A/S (the “Company”) has appointed Steven Projan, a current member of the company’s Board of Directors, to the company’s Nomination and Corporate Governance Committee effective May 12, 2021. With the appointment of Mr. Projan, the company’s Nomination and Corporate Governance Committee now consists of Marianne Søgaard, the Chairperson of the Company’s Board of Directors, Roberto Prego and Mr. Projan. The Board of Directors has determined that both Mr. Prego and Mr. Projan are “independent directors” as defined under current rules and regulations of the Securities and Exchange Commission and The Nasdaq Stock Market, LLC.